Back to Search
Start Over
Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors
- Source :
- Cancer, vol 119, iss 24, Hahn, EE; Hays, RD; Kahn, KL; Litwin, MS; & Ganz, PA. (2013). Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer, 119(24), 4316-4324. doi: 10.1002/cncr.28363. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6wd1d8th
- Publication Year :
- 2013
- Publisher :
- eScholarship, University of California, 2013.
-
Abstract
- BACKGROUND The American Society of Clinical Oncology (ASCO) recently released a "Top Five" list of opportunities to improve the quality of cancer care. Item 4 on the list advises against using advanced imaging and biomarkers for surveillance in patients with breast cancer who are treated with curative intent. This study examined concordance with ASCO follow-up care guidelines for breast cancer survivors treated at an academic medical center. METHODS Claims data and medical records were reviewed and abstracted for early stage breast cancer survivors starting 1 year post diagnosis. A trained abstractor classified imaging tests as diagnostic or surveillance. Proportions and frequencies were generated for receipt of services. Multilevel logistic regression was used to estimate factors associated with receiving recommended and nonrecommended services and biomarker tests. RESULTS Records were available for 258 patients. Mean age at diagnosis was 58 years (standard deviation of 13 years), mean time since diagnosis was 6 years (standard deviation of 2 years), and 71% were stage 0/1. Only 47% of the sample received a mammogram within 1 year of diagnosis, and 55% of the sample received at least 1 nonrecommended imaging service for surveillance purposes. Seventy-seven percent of the sample received at least 1 nonrecommended biomarker test. Regression results indicate that main treating physician, advanced disease stage, younger age at diagnosis, and greater number of years since diagnosis were associated with receiving nonrecommended services for surveillance. CONCLUSIONS Use of nonrecommended services for surveillance occurs frequently among early-stage breast cancer survivors. There are opportunities to increase use of guideline concordant posttreatment care for breast cancer survivors.
- Subjects :
- Diagnostic Imaging
Adult
Aging
Oncology and Carcinogenesis
Breast Neoplasms
and over
Medical Records
breast cancer
Clinical Research
80 and over
Humans
Oncology & Carcinogenesis
guideline adherence
health services
Aged
Cancer
screening and diagnosis
Tumor
Middle Aged
Continuity of Patient Care
4.1 Discovery and preclinical testing of markers and technologies
Detection
posttreatment care
Population Surveillance
surveillance
Public Health and Health Services
Biomedical Imaging
Female
Biomarkers
4.2 Evaluation of markers and technologies
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Cancer, vol 119, iss 24, Hahn, EE; Hays, RD; Kahn, KL; Litwin, MS; & Ganz, PA. (2013). Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer, 119(24), 4316-4324. doi: 10.1002/cncr.28363. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6wd1d8th
- Accession number :
- edsair.dedup.wf.001..164864a7cf0b7f54a4104f07b03e2cbc